Clinical Remissions In Three Otherwise Intractable Cancers Signal The ...
Oct 13, 2009 | Posted by: roboblogger | Full story: MediLexicon
Epeius Biotechnologies Corporation announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
|Biomarker Linked to Aggressive Breast Cancers, ...||Mon||Spotted Girl||2|
|Albany physician group cures gap in cancer busi...||Dec 4||zeldo||1|
|Farrah Fawcett's Anal Cancer: Fighting the Stigma (Jun '09)||Dec 3||Cheryl Arcella GC NY||31|
|Robot-assisted hysterectomies booming, but better? (Feb '13)||Nov 22||Sarai B||2|
|Robotic surgery vs. radiation, chemo for throat... (Apr '13)||Nov 15||David Pendarvis||2|
|College-age women often unaware of breast cance...||Nov 12||No One Cares||1|
|Block-by-Block Ashburn: Where Veterans Live, Wh...||Nov 10||Anonymous||1|